Psychedelics Stocks

This Psychedelics Co. May IPO With '$100M In Revenue,' Changing Mental Health Forever, Says VC Investor

In the evolving narrative of modern medicine, there's a new chapter being written by the pioneers at the helm of Mystic Ventures, where managing partner

Psychedelics Stock Mycotopia On The Move Following LOI To Merge With Ei.Ventures In $360M Transaction

Medical psychedelics company Mycotopia Therapies Inc. (OTCPK: TPIA) reported Wednesday that it has signed a letter of intent to acquire botanical psilocybin pioneer, Ei.Ventures in a transaction valued at $360 million.